BAIN CAPITAL INVESTORS LLC — 13F Holdings & Portfolio
CIK 1040508 · latest 13F-HR filed 2026-05-15
BAIN CAPITAL INVESTORS LLC manages $3.27B in 13F-reported U.S. long-equity assets across 7 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are BOBS (34.29%), SGRY (18.22%), AVAH (16.08%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 2 new positions, exited 2, added to 0, and trimmed 5.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$3.27B
Long-equity book
7
Distinct positions
2026-03-31
Filed 2026-05-15
+2 / −2 / ↑0 / ↓5
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Trims
- SURGERY PARTNERS INC-$176.3M -22.8%
- KESTRA MED TECHNOLOGIES LTD-$165.9M -24.8%
- AVEANNA HEALTHCARE HLDGS INC-$141.2M -21.2%
- WAYSTAR HLDG CORP-$114.4M -26.4%
- NUTANIX INC-$73.3M -26.5%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | BOBS DISC FURNITURE INC | BOBS | 09681N106 | $1.12B | 34.29% | 95,370,751 | SH |
| 2 | SURGERY PARTNERS INC | SGRY | 86881A100 | $595.4M | 18.22% | 49,946,972 | SH |
| 3 | AVEANNA HEALTHCARE HLDGS INC | AVAH | 05356F105 | $525.5M | 16.08% | 81,600,880 | SH |
| 4 | KESTRA MED TECHNOLOGIES LTD | KMTS | G52441105 | $501.7M | 15.35% | 25,172,338 | SH |
| 5 | WAYSTAR HLDG CORP | WAY | 946784105 | $319.3M | 9.77% | 13,243,539 | SH |
| 6 | NUTANIX INC | NTNX | 67059N108 | $203.6M | 6.23% | 5,355,285 | SH |
| 7 | ADVANTAGE SOLUTIONS INC | ADV | 00791N201 | $2.4M | 0.07% | 115,600 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $3.27B | 7 | 0001193125-26-225264 |
| 2025-12-31 | 2026-02-17 | $4.62B | 7 | 0001193125-26-052994 |
| 2025-09-30 | 2025-11-14 | $3.35B | 6 | 0001193125-25-281492 |